Chemomab to present at 5th Annual Antifibrotic Drug Development Summit
2:30 pm ET ─ Dr. Adi Mor: Panel Discussion: Creative Clinical Trial Designs
3:00 pm ET ─ Dr. Adi Mor: CCL24: A Central Regulator of Immune Modulation & Fibrosis
Investor Relations
2:30 pm ET ─ Dr. Adi Mor: Panel Discussion: Creative Clinical Trial Designs
3:00 pm ET ─ Dr. Adi Mor: CCL24: A Central Regulator of Immune Modulation & Fibrosis